Christopher Ryan Sullivan sold $179K of Avalo Therapeutics, Inc. (AVTX) stock

Christopher Ryan Sullivan, Chief Financial Officer of Avalo Therapeutics, Inc. (AVTX), sold 10,185 shares of AVTX stock worth $179K, per an SEC Form 4 filed Sep 11, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Sep 10, 2026, 1 day before it was made public.

AVTX has moved -3.9% since the trade date, from $17.18 to $16.51 (Sep 22, 2026 close).